Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK10 | P53779 | 2/20 | 0.33 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | LPL | P06858 | 1/20 | 0.30 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.30 |
| ▸ | HTR3A | P46098 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19653758 | 0.97 | TUBB4A (0.32) | MAPK10MAPK9PIK3CDPIK3CAMTOR | |
| SCHEMBL14849756 | 0.95 | LPL (0.34) | MAPK10MAPK9PIK3CDPIK3CAMTOR | |
| SCHEMBL10014048 | 0.94 | PIK3CD (0.33) | MAPK10MAPK9PIK3CDPIK3CAMTOR | |
| SCHEMBL19653491 | 0.94 | KDM4E (0.37) | PIK3CDPIK3CAMTORPGR | |
| SCHEMBL19653010 | 0.94 | KDM4E (0.37) | PIK3CDPIK3CAMTORPGR | |
| SCHEMBL17854702 | 0.93 | MAPK10 (0.34) | MAPK10MAPK9PIK3CDPIK3CAMTOR | |
| SCHEMBL19653038 | 0.93 | KDM4E (0.33) | PIK3CDPIK3CAMTOR | |
| SCHEMBL17760671 | 0.93 | KDM4E (0.33) | PIK3CDPIK3CAMTOR | |
| SCHEMBL19653759 | 0.92 | TUBB4A (0.32) | MAPK10MAPK9PIK3CDPIK3CAMTOR | |
| SCHEMBL17446048 | 0.91 | PIK3CD (0.31) | MAPK10MAPK9PIK3CDPIK3CAMTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9196837-B2 | Compound having indenocarbazole ring structure, and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2015-11-24 | — | — | US | disclosed |
| US-9196837-B2 | Compound having indenocarbazole ring structure, and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2015-11-24 | — | — | US | disclosed |
| US-20130126856-A1 | COMPOUND HAVING INDENOCARBAZOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2013-05-23 | — | — | US | disclosed |
| US-20130126856-A1 | COMPOUND HAVING INDENOCARBAZOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2013-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130126856-A1 | COMPOUND HAVING INDENOCARBAZOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | SLCO2B1, SLCO1B1, SLCO2A1 | MAPK10 3687/4885MAPK9 1435/4885PIK3CD 2613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.